Scimeca Jean-Claude, Quincey Danielle, Parrinello Hugues, Romatet Delphine, Grosgeorge Josiane, Gaudray Patrick, Philip Nicole, Fischer Alain, Carle Georges F
Instabilité et Altérations des Génomes, UMR6549 CNRS/UNSA, Faculté de Médecine de l'Université de Nice-Sophia Antipolis, Nice, France.
Hum Mutat. 2003 Feb;21(2):151-7. doi: 10.1002/humu.10165.
Fifty percent of the infantile malignant osteopetrosis (IMO) cases reported in the literature present mutations in the TCIRG1 gene encoding the 116-kDa osteoclast specific subunit of the vacuolar proton ATPase (ATP6I). In this study, we identified four novel mutations in a series of six IMO patients. All of these mutations correspond to single nucleotide changes and affect splice acceptor or donor sites, resulting in aberrant transcription products. We report also a missense mutation, G405R, previously described in several Costa Rican patients. This independent finding suggests that the highly conserved residue at amino acid 405 plays a critical role in the a3 subunit function. Finally, the results of this study were used to provide a prenatal diagnosis to one of the families.
文献报道的婴儿恶性骨硬化症(IMO)病例中,50%存在编码液泡质子ATP酶(ATP6I)116-kDa破骨细胞特异性亚基的TCIRG1基因突变。在本研究中,我们在一组6例IMO患者中鉴定出4种新突变。所有这些突变均对应单核苷酸变化,并影响剪接受体或供体位点,导致异常转录产物。我们还报告了一个错义突变G405R,此前在几名哥斯达黎加患者中已有描述。这一独立发现表明,第405位氨基酸处高度保守的残基在a3亚基功能中起关键作用。最后,本研究结果被用于为其中一个家庭提供产前诊断。